DOI:
10.1055/s-00000068
Seminars in Interventional Radiology
LinksClose Window
References
Eberhard DA, Johnson BE, Amler LC , et al.
Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib.
J Clin Oncol 2005;
23 (25) 5900-5909
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.